Xiamen Amoytop Biotech Co Ltd
SSE:688278
Wall Street
Price Targets
Price Targets Summary
Xiamen Amoytop Biotech Co Ltd
According to Wall Street analysts, the average 1-year price target for Xiamen Amoytop Biotech Co Ltd is 77.49 CNY with a low forecast of 50 CNY and a high forecast of 93.66 CNY.
Operating Income
Forecast
Operating Income Estimate
Xiamen Amoytop Biotech Co Ltd
For the last 5 years the compound annual growth rate for Xiamen Amoytop Biotech Co Ltd's operating income is 95%. The projected CAGR for the next 4 years is 43%.
Net Income
Forecast
Net Income Estimate
Xiamen Amoytop Biotech Co Ltd
For the last 5 years the compound annual growth rate for Xiamen Amoytop Biotech Co Ltd's net income is 123%. The projected CAGR for the next 4 years is 48%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Xiamen Amoytop Biotech Co Ltd's stock price target?
Price Target
77.49
CNY
According to Wall Street analysts, the average 1-year price target for Xiamen Amoytop Biotech Co Ltd is 77.49 CNY with a low forecast of 50 CNY and a high forecast of 93.66 CNY.
What is Xiamen Amoytop Biotech Co Ltd's Revenue forecast?
Projected CAGR
34%
For the last 5 years the compound annual growth rate for Xiamen Amoytop Biotech Co Ltd's revenue is 36%. The projected CAGR for the next 4 years is 34%.
What is Xiamen Amoytop Biotech Co Ltd's Operating Income forecast?
Projected CAGR
43%
For the last 5 years the compound annual growth rate for Xiamen Amoytop Biotech Co Ltd's operating income is 95%. The projected CAGR for the next 4 years is 43%.
What is Xiamen Amoytop Biotech Co Ltd's Net Income forecast?
Projected CAGR
48%
For the last 5 years the compound annual growth rate for Xiamen Amoytop Biotech Co Ltd's net income is 123%. The projected CAGR for the next 4 years is 48%.
You don't have any saved screeners yet
